BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 12839021)

  • 1. Availability and Coverage of New Drugs in 6 High-Income Countries With Health Technology Assessment Bodies.
    Wouters OJ; Naci H; Papanicolas I
    JAMA Intern Med; 2024 Mar; 184(3):328-330. PubMed ID: 38285561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
    Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
    J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.
    Minar E; Pokrajac B; Maca T; Ahmadi R; Fellner C; Mittlböck M; Seitz W; Wolfram R; Pötter R
    Circulation; 2000 Nov; 102(22):2694-9. PubMed ID: 11094034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions.
    Zehnder T; von Briel C; Baumgartner I; Triller J; Greiner R; Mahler F; Do DD
    J Endovasc Ther; 2003 Apr; 10(2):304-11. PubMed ID: 12877614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary brachytherapy for the prevention and management of restenosis.
    Tecnologica MAP Suppl; 2000 Dec; ():3-6. PubMed ID: 11503770
    [No Abstract]   [Full Text] [Related]  

  • 6. Brachytherapy for the prevention of restenosis in peripheral arteries following percutaneous transluminal angioplasty (PTA) of the femoropopliteal system.
    TEC Bull (Online); 2002 Nov; 19(3):10-2. PubMed ID: 12839021
    [No Abstract]   [Full Text] [Related]  

  • 7. Endovascular brachytherapy in peripheral arteries.
    Minar E; Pokrajac B; Budinsky A; Pötter R
    Vasa; 2003 Feb; 32(1):3-9. PubMed ID: 12677757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular brachytherapy in the femoropopliteal segment using 192Ir and 188Re.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    Cardiovasc Intervent Radiol; 2008; 31(4):698-708. PubMed ID: 18185955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular brachytherapy and restenosis following lower limb angioplasty: Systematic review and meta-analysis of randomized clinical trials.
    Mitchell D; O'Callaghan AP; Boyle EM; Kavanagh EG; Walsh SR
    Int J Surg; 2012; 10(3):124-8. PubMed ID: 22349154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiation therapy in the treatment of femoropopliteal occlusive disease.
    Chellini J; Ansel GM; Botti CF; Silver MJ
    J Invasive Cardiol; 2003 Jan; 15 Suppl A():21A-24A. PubMed ID: 12668838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoropopliteal artery obstructions: from the balloon to the stent-graft.
    Lammer J
    Cardiovasc Intervent Radiol; 2001; 24(2):73-83. PubMed ID: 11443390
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.